Clinical Trials Browser

Phase 2/3 × Adenomatous Polyposis Coli × Clear all

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00808743 2013-05-16

PreDuoFAP

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Phase 2/3 Unknown

90 enrolled

Gastrointestinal

Adenoma, Adenomatous Polyposis Coli

Clinical Trials

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

PreDuoFAP

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients